Handelsbanken Fonder Ab Heska Corp Transaction History

Handelsbanken Fonder Ab

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 27, 2022	SELL	$72.92 - $99.73 $3.86 Million - $5.29 Million	-53,000 Reduced 36.1%	93,800 $6.84 Million
Q2 2022 Aug 03, 2022	BUY	$84.23 - $147.57 $598,033 - $1.05 Million	7,100 Added 5.08%	146,800 $13.9 Million
Q1 2022 May 11, 2022	SELL	$122.89 - $171.74 $761,918 - $1.06 Million	-6,200 Reduced 4.25%	139,700 $19.3 Million
Q4 2021 Feb 08, 2022	BUY	$156.0 - $265.78 $2.06 Million - $3.51 Million	13,200 Added 9.95%	145,900 $26.6 Million
Q3 2021 Nov 10, 2021	BUY	$228.69 - $274.2 $45,738 - $54,840	200 Added 0.15%	132,700 $34.3 Million
Q2 2021 Aug 03, 2021	BUY	$169.89 - $231.37 $594,615 - $809,795	3,500 Added 2.71%	132,500 $30.4 Million
Q1 2021 Apr 29, 2021	BUY	$143.93 - $207.3 $18.6 Million - $26.7 Million	129,000 New	129,000 $21.7 Million

26K

Ticker HSKA
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 10,818,900
Description
Heska Corporation sells veterinary and animal health diagnostic and specialty products for canine and feline healthcare markets in the United States, Canada, Mexico, Australia, France, Germany, Italy, Malaysia, Spain, and Switzerland. The company offers Element DC, Element DCX, Element DC5x veterinary chemistry analyzers for blood chemistry and ...

Get notified when there are updates to the investment portfolio of Handelsbanken Fonder Ab, based on Form 13F filings with the SEC.

Stay updated on Handelsbanken Fonder Ab with notifications on news.